European agency OKs Moderna vaccine for children

By The Associated Press

LONDON — The European Medicines Agency has recommended clearing Moderna’s COVID-19 vaccine for children ages 12 to 17, the first time the shot has been authorized for people under 18.

In a decision on Friday, the EU drug regulator says research in more than 3,700 children ages 12 to 17 showed the Moderna vaccine — already approved for adults across Europe — produced a comparable antibody response.

Until now, the vaccine made by Pfizer and its German partner BioNTech has been the only option for children in North America and Europe. The U.S. Food and Drug Administration is currently considering whether to extend the use of the Moderna vaccine for children under 18.

With global vaccine supplies still tight, much of the world still is struggling to immunize adults, and agencies including the World Health Organization have urged rich countries to donate their doses to the developing world — where fewer than 2% of people have been vaccinated — rather than moving on to inoculate their younger, less vulnerable populations.

___

FILE – In this file photo dated Wednesday, Feb. 17, 2021, three vials of the Moderna COVID-19 Vaccine are pictured in a new coronavirus vaccination center at the ‘Velodrom’ (velodrome-stadium) in Berlin, Germany. The European Medicines Agency has recommended approving Moderna’s COVID-19 vaccine for children aged 12 to 17, the first time the shot has been authorized for people under 18. In a decision on Friday, July 23, 2021 the EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna vaccine — already given the OK for adults across Europe — produced a comparable antibody response. (AP Photo/Michael Sohn, File)

error: Content is protected !!